CoreValve's Series C Round

CoreValve raised a round of funding on March 20, 2007.

CoreValve aims to develop and commercialize products that aim to provide an alternative to heart valve replacement surgery. Its ReValving System received CE Mark approval in 2007 and has since become…

Articles about CoreValve's Series C Round: